Additional file 1: of An assessment of dental caries among young Aboriginal children in New South Wales, Australia: a cross-sectional study

Flow diagram explaining recruitment and data available based on STROBE [ 27 ]. Flow diagram explaining recruitment and data available based on STROBE. (DOCX 24 kb

Indices from the modelling of the data from the IVGTT.

<p>All values are mean (SEM), N = 12. Comparisons made with paired t-tests.</p

Insulin concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.

<p>N = 12, mean ± SEM. Significantly higher concentrations following HAM-RS2 compared with placebo (<i>p</i> = 0.009). Comparisons made with repeated measures ANOVA. Black circles  =  HAM-RS2; white circles  =  placebo.</p

Glucose concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.

<p>N = 12, mean ± SEM. No significant difference between the HAM-RS2 and placebo. Comparisons made with repeated measures ANOVA. Black circles  =  HAM-RS2; white circles  =  placebo; dashed line  =  baseline glucose concentrations.</p

C-peptide concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.

<p>N = 12, mean ± SEM. Significantly higher concentrations following HAM-RS2 compared with placebo (<i>p</i> = 0.016). Comparisons made with repeated measures ANOVA. Black circles  =  HAM-RS2; white circles  =  placebo.</p

Anthropometric measurements and fasting plasma concentrations taken after 4 weeks daily supplementation with either 40 g/day of HAM-RS2 or placebo.

<p>All values are mean (SEM), N = 12. Comparisons made with paired t-tests.</p>1<p>Measured by bioimpedance (Tanita, Arlington Heights, IL, USA). N = 11.</p>2<p>Mean of 3 readings taken with the subject in a sitting position, measured by an automatic blood pressure cuff (Omron MX3 Plus, Omron Healthcare Europe, Milton Keynes, United Kingdom).</p